EMEA launches consultation on its Road Map to 2015

The European Medicines Agency (EMEA) has launched a three-month public consultation on its Road Map to 2015, coinciding with its 15th anniversary on January 26, 2010, setting out the Agency's priorities for the next five years.

European and international partners, stakeholders, including patients' and doctors' organizations, as well as pharmaceutical industry, and the public are invited to make their views known on the Agency's future strategic vision, set out in the document 'The European Medicines Agency Road Map to 2015: The Agency's contribution to Science, Medicines, Health.' Comments should be sent using the Agency's comments form by April 30 to roadmap@ema.europa.eu.

Building on the achievements made by the previous Road Map initiative between 2005 and 2010, the focus of the new Road Map to 2015 is on continuous high-quality delivery of the Agency's core business in an increasingly complex regulatory and scientific environment. In addition, the document proposes three priority areas for future actions to strengthen the Agency's role in protecting and promoting human and animal health in the European Union. These include: